These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Botulinum toxin for the management of adult patients with upper motor neuron syndrome. Esquenazi A, Mayer NH, Elia AE, Albanese A. Toxicon; 2009 Oct; 54(5):634-8. PubMed ID: 19470335 [Abstract] [Full Text] [Related]
6. Evidence for the use of botulinum toxin in the chronic pain setting--a review of the literature. Jeynes LC, Gauci CA. Pain Pract; 2008 Oct; 8(4):269-76. PubMed ID: 18503628 [Abstract] [Full Text] [Related]
14. Botulinum Toxin A reduces neurogenic flare but has almost no effect on pain and hyperalgesia in human skin. Krämer HH, Angerer C, Erbguth F, Schmelz M, Birklein F. J Neurol; 2003 Feb; 250(2):188-93. PubMed ID: 12574949 [Abstract] [Full Text] [Related]
15. Neurobiological basis for the use of botulinum toxin in pain therapy. Mense S. J Neurol; 2004 Feb; 251 Suppl 1():I1-7. PubMed ID: 14991335 [Abstract] [Full Text] [Related]
17. The therapeutic use of botulinum toxin in cervical and maxillofacial conditions: an evidence-based review. Ihde SK, Konstantinovic VS. Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2007 Aug; 104(2):e1-11. PubMed ID: 17560141 [Abstract] [Full Text] [Related]